Calcium kinetics in glycogen storage disease type 1a

Area of Science:

• Biochemistry
• Bone Metabolism
• Pediatric Endocrinology

Background:

• Glycogen storage disease type 1a (GSD 1a), also known as Von Gierke's disease, is a common metabolic disorder.
• Patients with GSD 1a frequently develop severe idiopathic osteopenia, even at a young age.
• Calcium tracer studies are sensitive to bone microenvironment and calcium deposition dynamics.

Purpose of the Study:

• To investigate calcium plasma dilution kinetics in patients with GSD 1a.
• To compare calcium dynamics between GSD 1a patients and age-matched controls using a novel binding site model.
• To analyze potential disturbances in calcium deposition and kinetics at the plasma-bone interface in GSD 1a.

Main Methods:

• Utilized the stable isotope 42Ca for plasma dilution kinetic studies.
• Applied a new binding site model to describe calcium dynamics, including reversible binding to short-term and long-term sites.
• Analyzed kinetic parameters such as the retention probability density function psi (t).

Main Results:

• Demonstrated significant differences in plasma dilution kinetics between GSD 1a patients and controls.
• Adult GSD subjects showed a statistically significant decrease (P = 0.023) in the apparent half-life of calcium ions on longer-term bone sites compared to controls.
• The findings suggest impaired calcium homeostasis at the plasma-bone interface in GSD 1a.

Conclusions:

• Calcium kinetics are demonstrably altered in patients with Glycogen storage disease type 1a.
• The study highlights a reduced calcium retention on long-term bone sites, contributing to osteopenia in GSD 1a.
• The findings support the need for further investigation into calcium metabolism and bone health in GSD 1a patients.